Alera Investment Advisors, LLC Alkermes Plc. Transaction History
Alera Investment Advisors, LLC
- $734 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$729 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$504 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$372 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$225 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$208 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.11B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...